NYSE · NUS

NuSkin Enterprises, Inc.

$5.08 $0.00 (+0.00%) 1D After hours

Key Metrics

$246.64M
Market cap
4.52×
P/E · TTM
$1.44B
Revenue · TTM
$54.53M
Net income
EPS · TTM $1.08
Dividend yield 4.7%
Free cash flow $41.57M
Beta · 1Y 0.96
EBITDA · TTM $114.59M
Gross margin 69.3%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 25
    From its Feb 6 high, the share price fell 54%.

    Peak close $10.81 on Feb 6; trough close $4.94 on Jun 25. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -54%
  • Feb 13
    The stock moved -18.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 13
  • Feb 9
    The stock moved -8.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 9

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$246.64M
Enterprise value$269.82M
Shares outstanding48.6M
52-wk range$4.89 – $14.62
Avg volume · 20D618.0K
Net cash −$23.19M
Book value / share$15.78
IndustryWholesale-Drugs, Proprietaries & Druggists' Sundries
ExchangeNYSE
About NuSkin Enterprises, Inc.
IPO dateNov 22, 1996
Employees8600

Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E4.52
P/S0.17
P/FCF5.93
EV/EBITDA2.35
EV/Sales0.19
Graham №$19.61

Profitability

Gross 69.3%
Operating 4.5%
Net 3.8%
FCF 2.9%
ROE / ROIC 7.5% · 6.7%

Financial Health

Current ratio2.03
Quick ratio1.34
Debt / equity0.28
Debt / EBITDA 1.95
Net cash −$23.19M
Working capital$265.89M

Cash Flow · TTM

Operating CF $75.98M
Capex −$34.41M
Free cash flow $41.57M
Buybacks $20.04M
Dividends paid $11.71M
Shareholder yield 12.9%

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

3.6
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$19.61 vs $5.08
Trades below classic defensive value — Graham-cheap
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings